JP2024517769A5 - - Google Patents
Info
- Publication number
- JP2024517769A5 JP2024517769A5 JP2023566850A JP2023566850A JP2024517769A5 JP 2024517769 A5 JP2024517769 A5 JP 2024517769A5 JP 2023566850 A JP2023566850 A JP 2023566850A JP 2023566850 A JP2023566850 A JP 2023566850A JP 2024517769 A5 JP2024517769 A5 JP 2024517769A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- ring
- alkoxy
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/091510 | 2021-04-30 | ||
| CN2021091510 | 2021-04-30 | ||
| PCT/US2022/026832 WO2022232459A1 (en) | 2021-04-30 | 2022-04-28 | Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517769A JP2024517769A (ja) | 2024-04-23 |
| JP2024517769A5 true JP2024517769A5 (https=) | 2025-05-01 |
Family
ID=81748636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566850A Pending JP2024517769A (ja) | 2021-04-30 | 2022-04-28 | Ｌｐａアンタゴニストとしての新規トリアゾール－ピリジン置換ピロリジニル及びテトラヒドロ－２ｈ－ピラニル酢酸化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250230140A1 (https=) |
| EP (1) | EP4330249A1 (https=) |
| JP (1) | JP2024517769A (https=) |
| KR (1) | KR20240044386A (https=) |
| CN (1) | CN117751106A (https=) |
| AU (1) | AU2022264579A1 (https=) |
| CA (1) | CA3218258A1 (https=) |
| IL (1) | IL308035A (https=) |
| MX (1) | MX2023012830A (https=) |
| WO (1) | WO2022232459A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023109878A1 (zh) * | 2021-12-15 | 2023-06-22 | 武汉人福创新药物研发中心有限公司 | 三氮唑类lpar1拮抗剂及其用途 |
| WO2025051267A1 (zh) * | 2023-09-08 | 2025-03-13 | 西藏海思科制药有限公司 | 一种lpar1拮抗剂及其用途 |
| WO2025051266A1 (zh) * | 2023-09-08 | 2025-03-13 | 西藏海思科制药有限公司 | 杂芳环衍生物的lpar1拮抗剂及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019126084A1 (en) * | 2017-12-19 | 2019-06-27 | Bristol-Myers Squibb Company | Isoxazole o-linked carbamoyl cyclohexyl acids as lpa antagonists |
| JP7208240B2 (ja) * | 2017-12-19 | 2023-01-18 | ブリストル－マイヤーズ スクイブ カンパニー | Ｌｐａアンタゴニストとしてのシクロヘキシル酸トリアゾールアジン |
| ES2946657T3 (es) * | 2018-09-18 | 2023-07-24 | Bristol Myers Squibb Co | Acidos ciclopentílicos como antagonistas de LPA |
| CN111434655A (zh) * | 2019-01-15 | 2020-07-21 | 武汉朗来科技发展有限公司 | 溶血磷脂酸受体拮抗剂及其制备方法 |
| WO2020257135A1 (en) * | 2019-06-18 | 2020-12-24 | Bristol-Myers Squibb Company | Triazole carboxylic acids as lpa antagonists |
| WO2022034568A1 (en) * | 2020-08-11 | 2022-02-17 | Viva Star Biosciences Limited | Triazole-pyridinyl substituted azacyclohexyl acetic acid compounds as lpa receptor antagonists |
-
2022
- 2022-04-28 CN CN202280040512.3A patent/CN117751106A/zh active Pending
- 2022-04-28 IL IL308035A patent/IL308035A/en unknown
- 2022-04-28 EP EP22724318.5A patent/EP4330249A1/en active Pending
- 2022-04-28 AU AU2022264579A patent/AU2022264579A1/en active Pending
- 2022-04-28 CA CA3218258A patent/CA3218258A1/en active Pending
- 2022-04-28 MX MX2023012830A patent/MX2023012830A/es unknown
- 2022-04-28 US US18/557,918 patent/US20250230140A1/en active Pending
- 2022-04-28 WO PCT/US2022/026832 patent/WO2022232459A1/en not_active Ceased
- 2022-04-28 JP JP2023566850A patent/JP2024517769A/ja active Pending
- 2022-04-28 KR KR1020237041165A patent/KR20240044386A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023544476A5 (https=) | ||
| JP2024517769A5 (https=) | ||
| JP2020510015A5 (https=) | ||
| JP2014531434A5 (https=) | ||
| JP2008508214A (ja) | 女性の性障害の治療用ピペラジン誘導体 | |
| US20080182845A1 (en) | Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection | |
| JP2019094345A5 (https=) | ||
| JP2018524339A5 (https=) | ||
| JP2021508686A5 (https=) | ||
| JP2013502431A5 (https=) | ||
| JP2020517711A5 (https=) | ||
| JP2017516826A5 (https=) | ||
| JP2018536648A5 (https=) | ||
| JP2020510010A5 (https=) | ||
| JP2018529745A5 (https=) | ||
| JP2021535174A5 (https=) | ||
| JP2021535177A5 (https=) | ||
| RU2012110007A (ru) | Имидазохинолины в качестве двойных ингибиторов липидкиназы и mtor | |
| JP2009523841A5 (https=) | ||
| JP2022522486A5 (https=) | ||
| JP2019519586A5 (https=) | ||
| JP2022500425A5 (https=) | ||
| JP2013508452A5 (https=) | ||
| US20160175316A1 (en) | Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection | |
| JP2023504544A5 (https=) |